AIDS. Preliminary investigative research is ongoing at present to establish an in vitro model for the efficacy of either phenylacetate or phenylbutyrate for inhibiting the replication of the AIDS virus. Estimated research time to develop model is approximately three years.
Appears in 2 contracts
Sources: Sublicense Agreement (Somanta Pharmaceuticals Inc.), Sublicense Agreement (Somanta Pharmaceuticals Inc.)